SI
OCGN icon

Sofinnova Investments’s Ocugen OCGN Stock Holding History

Sofinnova Investments’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-34,617
Closed -$1.13M – 68
2018
Q3 		$1.13M Hold
34,617
– – 0.1% 58
2018
Q2 		$5.19M Hold
34,617
– – 0.59% 33
2018
Q1 		$5.71M Buy
+34,617
New +$5.52M 0.98% 12

Other funds holding OCGN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sofinnova Investments's OCGN Position: Q4 2018 in Review

Sofinnova Investments sold out of Ocugen (OCGN) in Q4 2018, closing a stake of 34,617 shares — an estimated $1.13M sold.

Sofinnova Investments first reported a position in OCGN in Q1 2018 and held it in 3 quarters. The position peaked at $5.71M in Q1 2018. 27 funds tracked by Wall St. Rank hold OCGN as of Q4 2018.

  • Sofinnova Investments reported no remaining Ocugen position as of Q4 2018 after selling out during the quarter.
  • Sofinnova Investments sold 34,617 Ocugen shares in Q4 2018, an estimated $1.13M.
  • Sofinnova Investments first reported a position in Ocugen in Q1 2018 and held it in 3 quarters.
  • Sofinnova Investments's Ocugen position peaked at $5.71M in Q1 2018.
  • 27 funds tracked by Wall St. Rank held Ocugen as of Q4 2018.

Based on Sofinnova Investments's 13F filing for Q4 2018, filed 14 Feb 2019.